Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats

Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal... Graefes Arch Clin Exp Ophthalmol (2017) 255:1581–1592 DOI 10.1007/s00417-017-3690-1 BASIC SCIENCE Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats 1 2 2 1 Biji Mathew & Jacqueline N. Poston & John C. Dreixler & Leianne Torres & 1 3 4 4 Jasmine Lopez & Ruth Zelkha & Irina Balyasnikova & Maciej S. Lesniak & 1,3 Steven Roth Received: 18 January 2017 /Revised: 19 April 2017 /Accepted: 26 April 2017 /Published online: 18 May 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract STR, and P2, and attenuated apoptosis as evidenced by de- Purpose Ischemia-associated retinal degeneration is one of creased TUNEL and caspase-3 protein levels. BMSCs signif- the leading causes of vision loss, and to date, there are no icantly increased autophagy, decreased inflammatory media- effective treatment options. We hypothesized that delayed in- tors (TNF-α, IL-1β, IL-6), and diminished retinal vascular jection of bone-marrow stem cells (BMSCs) 24 h after the permeability. BMSCs persisted in the vitreous and were also onset of ischemia could effectively rescue ischemic retina found within ischemic retina. from its consequences, including apoptosis, inflammation, Conclusions Taken together, our results indicate that intravit- and increased vascular permeability, thereby preventing reti- real injection of BMSCs rescued http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Graefe's Archive for Clinical and Experimental Ophthalmology Springer Journals

Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats

Loading next page...
 
/lp/springer_journal/bone-marrow-mesenchymal-stem-cell-administration-significantly-ZKKnlf2DtV
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Ophthalmology
ISSN
0721-832X
eISSN
1435-702X
D.O.I.
10.1007/s00417-017-3690-1
Publisher site
See Article on Publisher Site

Abstract

Graefes Arch Clin Exp Ophthalmol (2017) 255:1581–1592 DOI 10.1007/s00417-017-3690-1 BASIC SCIENCE Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats 1 2 2 1 Biji Mathew & Jacqueline N. Poston & John C. Dreixler & Leianne Torres & 1 3 4 4 Jasmine Lopez & Ruth Zelkha & Irina Balyasnikova & Maciej S. Lesniak & 1,3 Steven Roth Received: 18 January 2017 /Revised: 19 April 2017 /Accepted: 26 April 2017 /Published online: 18 May 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract STR, and P2, and attenuated apoptosis as evidenced by de- Purpose Ischemia-associated retinal degeneration is one of creased TUNEL and caspase-3 protein levels. BMSCs signif- the leading causes of vision loss, and to date, there are no icantly increased autophagy, decreased inflammatory media- effective treatment options. We hypothesized that delayed in- tors (TNF-α, IL-1β, IL-6), and diminished retinal vascular jection of bone-marrow stem cells (BMSCs) 24 h after the permeability. BMSCs persisted in the vitreous and were also onset of ischemia could effectively rescue ischemic retina found within ischemic retina. from its consequences, including apoptosis, inflammation, Conclusions Taken together, our results indicate that intravit- and increased vascular permeability, thereby preventing reti- real injection of BMSCs rescued

Journal

Graefe's Archive for Clinical and Experimental OphthalmologySpringer Journals

Published: May 18, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off